Are you attending the 4th Chief Patient Officer Summit happening now in Boston, MA? Our fabulous teammates Kimberly Cline, Jasmine Patel, MPH, Claire Long, and John Kelly are on-site with colleagues from across the industry, advancing the work needed to ensure that the patient experience is reflected at every stage of operations. As a proud sponsor of this year’s event, Envision is committed to supporting improved engagement, advocacy, communications, and support services for people living with disease. #DGEvents #CPOSummit #Patient #PatientExperience
About us
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 20 of the top 20 pharmaceutical companies. We have earned the reputation of a best-in-class partner for medical affairs teams, with expertise in leading medical strategy, medical communications, publication planning & delivery, patient engagement, and more. And through our comprehensive suite of services and industry-leading technology solutions - including Two Labs, Okra.ai, Riparian, and 90TEN - we support clients across the product life cycle. Clients come to us for expertise in artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Our purpose-built software, scientific solutions, and behavior change expertise make us a unique partner to the pharmaceutical industry.
- Website
-
http://www.envisionpharmagroup.com/
External link for Envision Pharma Group
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Global
- Type
- Privately Held
- Specialties
- Publication & Scientific Solutions, Technology Solutions, Grant management solutions, Market Access Solutions, Medical Communications Solutions, PR, Corporate Communications, Commercialisation, HEOR, Business Consulting & Strategic Solutions, Patient Communications, MSL Solutions, Document Collaboration, Strategic Consulting, Marketing Intelligence, Competitor Intelligence, Change Management, Operational Excellence, Publications Software, SaaS Solutions for Medical Affairs, Government Pricing, State Licensing, and Creative, Digital, Omnichannel
Locations
Employees at Envision Pharma Group
Updates
-
Unlocking the potential of oncology assets isn't just about groundbreaking science – it's about asking the right questions from day one. 💡 In this International Pharmaceutical Industry Journal article, Jason Gilbody, Principal, Strategic Consulting at Envision Pharma Group and co-lead of Envision Oncology Solutions, explores how strategic insights can help shape successful commercialization. From informed decision-making to effective product launches, discover why the questions you ask at the outset are crucial for your asset's journey to market. Read the full article to learn how smart questioning can revolutionize your oncology asset's path from development to success. 👇 https://lnkd.in/eSh_7Ag8 #Oncology #LifeSciences #HealthcareInnovation
-
In our webinar, "Medical, reimagined: How technology-driven insights can help us rethink strategy and execution," we engaged with participants to explore their perspectives on the technology advancements in healthcare. We delved into the challenges they encounter while integrating new technologies into medical affairs to create a more efficient, effective, and inspiring scientific future for pharma. Discover our report and contact us for the webinar recording 👉 bais@envisionpharma.com.
-
Emerging pharma companies face immense challenges in navigating the complex path to commercialization. 🧬 In our latest eBook, we take a deep dive into a success story that fueled the incredible growth of an emerging pharma company. Through a strategic partnership, we helped our client overcome key obstacles, clearing the path for their commercial success. The result? A remarkable transformation into a thriving organization valued at $6.7 billion. Download our eBook to learn how strategic transformation can position your biotech for sustained success. 👇 https://lnkd.in/esGyK-vF #HealthcareInnovation #LifeSciences #GrowthStrategy
-
What an amazing accomplishment for 90TEN! These accolades recognize the incredible work 90TEN has done, particularly in partnership with Novartis on the COSMOS program. Their efforts are equipping HCPs with essential tools to enhance MS services, showcasing the exceptional impact of their initiatives. Congratulations to the entire 90TEN team. Your achievements elevate Envision’s capabilities, allowing us to deliver even greater value to our clients. #CommuniqueAwards #ProfessionalEducation #HealthcareExcellence #EnvisionPharma #90TEN #Novartis #COSMOS #LifeSciences
We’re so excited to announce that we are winners at this year’s Communique award for Professional Education Programmes and highly commended for Excellence in National or Local Education Meetings/Standalone Events Award! We’re sharing these awards with our Novartis Clients for their work on the COSMOS programme to give HCPs the tools to drive positive change in their MS services. Huge congratulations to all tonight’s nominees and winners. #COMMUNIQUE #medcomms #healthcarecomms #healthcare #cxhealth #communiqueawards2024
-
In our recent webinar, “Medical, reimagined: How technology-driven insights can help us rethink strategy and execution,” we aimed to go beyond the theory, offering a concrete vision of how AI can redefine every facet of medical work to be more efficient, effective, and inspiring for the scientific future of pharma. Hear from Jim Streeter, President of Technology, CTO at Envision Pharma Group, about how AI can be a real game changer for the future of life sciences. To watch the full recording, reach us at 👉 bais@envisionpharma.com.
-
Two Labs Kyle Felmet and Riparian LLC’s Jennifer Lospinoso co-authored an insightful blog that highlights key strategies and innovative methods shaping the future of cell and gene therapy. Discover how early planning and new approaches ensure these cutting-edge therapies reach patients quickly and effectively.
Dive into our latest blog, where Kyle Felmet and Riparian LLC's Jennifer Lospinoso discuss transformative strategies and key considerations that are shaping the commercialization of cell and gene therapies (CGT). Their analysis covers the rapid advancements in CGT, the strategic planning required for successful market entry, and the innovative distribution models that ensure these groundbreaking treatments reach patients effectively. https://bit.ly/4boUaQl
-
As #Pride Month 2024 draws to a close, Envision Pharma Group is proud to support the power of pride and allyship that has been displayed by our people across the globe. While raising money for local LGBTQI+ charities, we have enjoyed cake bakes, a Pride playlist, origami making, Pride picnics, and LGBTQI+-themed quizzes! This month has also seen us partner with the Proud Science Alliance, joining them in their aim to further LGBTQI+ inclusion in the healthcare and life sciences sector globally.
-
Last week, two of our Envision Pharma Group teammates from 90TEN, Robert Goodwin and Sarah Avent attended Patient Centricity & Engagement Conference in Amsterdam, Netherlands- and left feeling optimistic about the industry's direction! With a growing number of pharma companies learning from one another, collaborating and endorsing each other’s work, they anticipate a further culture shift forward for patient involvement in medicine development. We can't wait to see how Sarah and Rob will bring to life the inspiring new ideas shared on demonstrating the internal and external value of patient community partnerships! #patientengagement
-
In our recent webinar “Medical, reimagined: How technology-driven insights can help us rethink strategy and execution,” we envisioned the future of medical affairs, focusing on the transformative roles of AI and tech solutions for life sciences. Here are the key insights: Reevaluating medical affairs: We explored evolving responsibilities, including data collection, evidence generation, key opinion leader engagement, and authentic healthcare professional (HCP) interactions, envisioning a data-based approach for the future. Unlocking data: The need to gather data from both private and public sources is crucial for enabling more personalized and impactful interactions with healthcare professionals. AI plays a vital role in generating these valuable insights. AI-powered insights: Leveraging large language models and multimodal models, AI's dynamic analysis of data from many sources can significantly shorten the cycle from evidence to practice, offering deeper, actionable insights for patient care. Revolutionizing information delivery: AI tailors medical information to HCPs' needs, improving accessibility and decision-making, thus elevating patient care. When we don’t even notice AI working in the background for us will be the time that it’s revolutionary. Our session transcended theory, presenting a concrete vision of AI's potential to redefine medical affairs – making it more efficient, effective, and inspiring the future of pharma. The time to action is NOW. To watch the full recording, reach us at 👉 bais@envisionpharma.com